GTC Biotherapeutics (fka GTCB)

[keitern]

>>GTCBs yearly burn rate is estimated at around 28mil/year<<

Seems a little light. more like 32

>>The recent acquisition of 7mil via share float actually provides about one quarter's running costs.<<

Wasn't this only 5.5?

>>Estimated revenue from H AT3 in Europe is in the range of 7mil and might be more<<

I remember 5mil being tossed around.

>>This total is enough to get them till the begining of 2009<<

I think this is way off.

I think we need a partnership/milestones of at least 10mil this year and then, although we won't be completely out of cash, we will still need more financing to avoid a "going concern" from the auditors.

We have some tough sledding to do in the financing field IMO. Hope I am wrong.